Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

Opening Session Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Sep
18
Today In Oncology
Cancer-Induced Nerve Injury Identified as Driver of PD-1 Resistance Across Tumor Types
Study Finds Postapproval Cancer Trials Fell After Inflation Reduction Act
Incorporating Family Caregivers Into Shared Decision-Making for Patients With Cancer
Clear-Margin Diagnostic Excisional Biopsy May Adequately Treat Melanoma in Situ, Study Finds
Is TBI Associated With Malignant Brain Tumors
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo